Profound Synergistic Bradycardia: Pharmacokinetic Consequences of Paxlovid-Mediated CYP3A4 and CYP2D6 Inhibition on Ranolazine, Diltiazem, and Metoprolol. [PDF]
Bactawar SB, Gaibor C, Abdul-Waheed M.
europepmc +1 more source
The ODYSSEY-HCM and MAPLE-HCM studies: the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy (obstructive and non-obstructive). [PDF]
Biagini E, Schiavo MA.
europepmc +1 more source
Estimation of Beta-Blocker Consumption in the Urban Population Using the Wastewater-Based Epidemiology Approach. [PDF]
Beldean-Galea MS +7 more
europepmc +1 more source
Protective effects of beta-blockers against anthracycline- and trastuzumab-related cardiotoxicity: a systematic review based on conventional and Bayesian network meta-analysis. [PDF]
Jiang S, Gao G.
europepmc +1 more source
Evolving strategies in obstructive hypertrophic cardiomyopathy: myosin inhibitors as monotherapy compared with beta-blockers. [PDF]
Grupper A +4 more
europepmc +1 more source
Versatile Graphene Oxide and Its Organo-Modified Analogs for the Removal of Pharmaceutical Compounds. [PDF]
Fragnaud E +7 more
europepmc +1 more source
Early metoprolol use in ICU patients with congestive heart failure is associated with increased 30-day mortality: a causal machine learning study. [PDF]
Chen Y, Li T.
europepmc +1 more source
A Case of Peripartum Cardiogenic Shock Resulting From Reverse Takotsubo Cardiomyopathy. [PDF]
Tarar N +5 more
europepmc +1 more source
Manuscript DMD-D-25-00346 The impact of glycocalyx on partitioning and distribution of basic drugs. [PDF]
Gong Y +5 more
europepmc +1 more source

